TADA2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.744170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.858400E-01
Normal-vs-Stage2
1.507990E-01
Normal-vs-Stage3
2.160200E-01
Normal-vs-Stage4
5.859600E-01
Stage1-vs-Stage2
6.617800E-01
Stage1-vs-Stage3
5.696100E-03
Stage1-vs-Stage4
8.387000E-01
Stage2-vs-Stage3
4.461700E-02
Stage2-vs-Stage4
5.909200E-01
Stage3-vs-Stage4
3.822200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.589250E-01
Normal-vs-AfricanAmerican
5.415600E-01
Normal-vs-Asian
4.218400E-01
Caucasian-vs-AfricanAmerican
5.617600E-01
Caucasian-vs-Asian
8.485000E-01
AfricanAmerican-vs-Asian
7.839600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.616810E-01
Normal-vs-Female
2.166600E-01
Male-vs-Female
3.654600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.559400E-01
Normal-vs-Age(41-60Yrs)
5.655600E-01
Normal-vs-Age(61-80Yrs)
2.106000E-01
Normal-vs-Age(81-100Yrs)
3.436400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.701800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.318400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.237400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.204200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.632200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.217800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.691900E-02
Normal-vs-Daily Drinker
1.727010E-01
Normal-vs-Weekly Drinker
1.882420E-01
Normal-vs-Occasional Drinker
2.924800E-01
Normal-vs-Social Drinker
4.475200E-01
Non Drinker-vs-Daily Drinker
4.336000E-01
Non Drinker-vs-Weekly Drinker
9.760200E-01
Non Drinker-vs-Occasional Drinker
1.552820E-01
Non Drinker-vs-Social Drinker
7.026400E-02
Daily Drinker-vs-Weekly Drinker
5.558400E-01
Daily Drinker-vs-Occasional Drinker
5.342600E-01
Daily Drinker-vs-Social Drinker
2.999400E-01
Weekly Drinker-vs-Occasional Drinker
2.940400E-01
Weekly Drinker-vs-Social Drinker
1.845570E-01
Occasional Drinker-vs-Social Drinker
6.526200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.799160E-01
Normal-vs-Grade 2
5.503200E-01
Normal-vs-Grade 3
5.367200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.820400E-01
Grade 1-vs-Grade 3
7.600800E-01
Grade 1-vs-Grade 4
1.799160E-01
Grade 2-vs-Grade 3
6.868000E-01
Grade 2-vs-Grade 4
5.503200E-01
Grade 3-vs-Grade 4
5.367200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.806000E-02
Normal-vs-NonDiabetic
1.793750E-01
Diabetic-vs-NonDiabetic
6.493000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.670800E-01
Normal-vs-NoPancreatitis
1.726410E-01
Pancreatitis-vs-NoPancreatitis
7.157400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.464200E-01
Normal-vs-N1
1.736620E-01
N0-vs-N1
8.430400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.841200E-01
Normal-vs-TP53-NonMutant
6.535800E-01
TP53-Mutant-vs-TP53-NonMutant
1.063420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
